C-reactive protein is associated with heart rate variability

Annals of Noninvasive Electrocardiology

Volumn 12, Issue 3, 2007, Pages 216-222

  Madsen, Trine ^a   Christensen, Jeppe Hagstrup ^a   Toft, Egon ^a,b   Schmidt, Erik Berg ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

C reactive protein; Coronary heart disease; Heart rate variability; Inflammation; Sudden cardiac death

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART INFARCTION; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SUDDEN DEATH;

ADULT; AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 34447131516     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2007.00164.x     Document Type: Article

References (19)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340 : 115 126.
2. Ridker PM, Rifai N, Pfeffer MA, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999 100 : 230 235.
3. Toss H, Lindahl B, Siegbahn A, et al. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. Circulation 1997 96 : 4204 4210.
4. Koenig W, Sund M, Frohlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999 99 : 237 242.
5. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997 336 : 973 979.
6. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 : 499 511.
7. Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002 105 : 2595 2599.
8. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996 93 : 1043 1065.
9. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 1999 50 : 249 261.
10. Christensen JH, Skou HA, Fog L, et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 2001 103 : 651 657.
11. Madsen T, Christensen JH, Blom M, et al. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: A dose-response study. Br J Nutr 2003 89 : 517 522.
12. Sajadieh A, Nielsen OW, Rasmussen V, et al. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004 25 : 363 370.
13. Jensen-Urstad M, Jensen-Urstad K, Ericson M, et al. Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 1998 243 : 33 40.
14. Janszky I, Ericson M, Lekander M, et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004 256 : 421 428.
15. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001 12 : 294 300.
16. Shehab AM, MacFadyen RJ, McLaren M, et al. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: A pilot study. Heart 2004 90 : 1263 1268.
17. Molgaard H, Sorensen KE, Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res 1991 1 : 233 237.
18. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: The Framingham Study. Am Heart J 1987 113 : 799 804.
19. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992 85 : I77 I91.